Pulmonary artery contractility in pneumonia: Role of cyclooxygenase products and nitric oxide

Citation
A. Yaghi et Dg. Mccormack, Pulmonary artery contractility in pneumonia: Role of cyclooxygenase products and nitric oxide, J CARDIO PH, 34(3), 1999, pp. 468-474
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
ISSN journal
01602446 → ACNP
Volume
34
Issue
3
Year of publication
1999
Pages
468 - 474
Database
ISI
SICI code
0160-2446(199909)34:3<468:PACIPR>2.0.ZU;2-Y
Abstract
The purpose of this study was to determine the effects of aminoguanidine (A G) and meclofenamate (MEC) on depressed contractility of small pulmonary ar tery (PA) rings isolated from a rat model of acute Pseudomonas pneumonia. C ontractility of PA rings from lungs of control or pneumonia rats was assess ed in vitro by obtaining cumulative concentration-contraction curves to pot assium chloride (KCI), phenylephrine (PE), and prostaglandin F-2 alpha (PGF (2 alpha)) on rings treated with or without MEC (1.0 mu M), AG (100 mu M), or AG + MEG. Vessels from pneumonia rats exhibited significant attenuation of the contractile responses to KCI, PE, and PGF(2 alpha). MEC restored the KCI and PGF(2 alpha) contractile responses to control values, but had no e ffect on the attenuated PE contractile response. In contrast, AG restored t he PE contractile response, and only partially affected contractile respons es to KCI and PGF(2 alpha), MEC + AG restored the contractile responses of all three agonists. We conclude that both excess nitric oxide (NO) and cycl ooxygenase products contribute to the depressed pulmonary vascular contract ility observed in rats with acute pneumonia. The relative importance of NO and cyclooxygenase products in this phenomenon depends on the contractile a gonist studied.